Trafalgar International GCAN
OTC GCAN
$0.35 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Shares Outstanding (2016 - 2026)

Trafalgar International (GCAN) posted Shares Outstanding (Entity) of $944935.0 for Q1 2026, little changed on a QoQ basis from $944935.0 in Q4 2025, and down 99.9% year-over-year from $974.9 million in Q1 2025.

Analysis

Trafalgar International (GCAN) Shares Outstanding (2016 - 2026) Analysis & Trends

Trafalgar International has reported Shares Outstanding (Entity) for 11 years, with the latest figure at $944935.0 in Q1 2026.

  • On a quarterly basis, Shares Outstanding (Entity) fell 99.9% year-over-year to $944935.0 in Q1 2026; TTM through Mar 2026 was $944935.0, a 99.9% decrease from a year earlier, with the FY2025 full-year figure at $944935.0, down 99.88% from the prior year.
  • Shares Outstanding (Entity) was $944935.0 for Q1 2026 at Trafalgar International, roughly flat from $944935.0 in the prior quarter.
  • The five-year high for Shares Outstanding (Entity) was $1.3 billion in Q2 2025, with the low at $900256.0 in Q3 2025.
  • Average Shares Outstanding (Entity) over 5 years is $640.2 million, with a median of $732.6 million recorded in 2023.
  • The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) soared 67.76% in 2025, then slumped 99.9% in 2026.
  • Over 5 years, Shares Outstanding (Entity) stood at $587.8 million in 2022, then soared by 36.9% to $804.6 million in 2023, then changed by 0.0% to $804.6 million in 2024, then plunged by 99.88% to $944935.0 in 2025, then changed by 0.0% to $944935.0 in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $944935.0 (Q1 2026), $944935.0 (Q4 2025), and $900256.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 2.41 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 1.77 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 1.94 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 5.70 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 1.22 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 210.89 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 200.38 Mn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 42.60 Mn
10 Trafalgar International 217,335.05 217,335.05 - 944,935.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 944,935.00
Dec 31, 2025 824,984.00
Sep 30, 2025 900,256.00
Jun 30, 2025 1.29 Bn
Mar 31, 2025 910.37 Mn
Dec 31, 2024 804.64 Mn
Sep 30, 2024 804.64 Mn
Jun 30, 2024 804.64 Mn
Mar 31, 2024 732.64 Mn
Dec 31, 2023 755.15 Mn
Sep 30, 2023 766.68 Mn
Jun 30, 2023 732.64 Mn
Mar 31, 2023 732.64 Mn
Dec 31, 2022 587.77 Mn
Sep 30, 2022 617.92 Mn
Jun 30, 2022 516.97 Mn
Mar 31, 2022 508.64 Mn
Dec 31, 2021 489.50 Mn
Sep 30, 2021 492.98 Mn
Jun 30, 2021 478.64 Mn